# Huons Biopharma breaks ground on $53M botulinum toxin plant in Jecheon

Huons Biopharma held a groundbreaking ceremony for its third plant at Jecheon Industrial Complex No. 1, investing 70 billion won (approx. $53 million) to expand production capacity for its botulinum toxin product Liztox. The plant is expected to be completed by 2024.

- Type: Expansion
- Announced: 2023-07-25
- Where: Jecheon Industrial Complex No. 1, Jecheon, South Korea, South Korea
- Value: $53.0M (70.0B KRW)
- Starts operating: 2024
- Status: under construction
- Products: botulinum toxin (Liztox)
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Huons BioPharma](https://endata.com/companies/58698.md)

## Sources

- [globalnewsagency.kr](https://www.globalnewsagency.kr/news/articleView.html?idxno=298905), 2023-07-25: "해당기업은 2021년 바이오사업을 위해 휴온스글로벌로부터 물적 분할되어 설립된 독립법인으로 제1산업단지 기존부지에 700억원을 투입하여 연면적 10,744㎡, 지상 5층 규모의 공장 증축을 시작하였으며, 2024년까지 새로운 공장을 완공 후 설비를 갖추고 생산역량을 늘려 보툴리눔 톡신 제제인 리즈톡스의 해외진출을 본격화 할 계획"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.